Salva Francisco D.
Transaction: 06/16/2026
SELL
Change
-500
Price
Not reported
Filing
06/18/2026
Type
SELL
Azitra, Inc.
AZTR • Biotechnology
$0.18
▼ -0.00 (-0.28%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$3.46M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 93.7%Manageable debt level · 0.11Healthy liquidity · 2.83Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:42 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.18
Change-0.28%
Shares Out19.30M
Market Cap$3.46M
Enterprise Value$-6.31B
52W Range0.10 - 1.40
Beta-1.18
P/E-0.62
P/B0.00
P/FCF-0.00
EV/EBITDA1,297.55
EV/FCF1.08
Price$0.18
Change-0.28%
Shares Out19.30M
Market Cap$3.46M
Enterprise Value$-6.31B
52W Range0.10 - 1.40
Beta-1.18
P/E-0.62
P/B0.00
P/FCF-0.00
EV/EBITDA1,297.55
EV/FCF1.08
Earnings Yield-160.99%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.11
Current Ratio2.83
Quick Ratio2.83
Revenue 5Y-100.00%
Volume1.09M
Avg Volume11.12M
EPS Surprise-0.24
Investment DNA
How strong this company looks for long-term investors
56
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive revenue growth · 93.7%Manageable debt level · 0.11Healthy liquidity · 2.83Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
Salva Francisco D.
Transaction: 06/16/2026
BUY
Change
+4,064,050
Price
Not reported
Filing
06/18/2026
Type
BUY
Whitfill Travis
Transaction: 04/20/2026
BUY
Change
+64,300
Price
$0.21
Filing
04/22/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Salva Francisco D. | SELL | -500 | Not reported | 06/16/2026 | 06/18/2026 |
| Salva Francisco D. | BUY | +4,064,050 | Not reported | 06/16/2026 | 06/18/2026 |
| Whitfill Travis | BUY | +64,300 | $0.21 | 04/20/2026 | 04/22/2026 |
| Salva Francisco D. | BUY | +220,879 | $0.21 | 04/20/2026 | 04/22/2026 |
| Staskey Norm | BUY | +35,524 | $0.21 | 04/20/2026 | 04/22/2026 |
| Salva Francisco D. | BUY | +500 | $0.12 | 03/18/2026 | 03/20/2026 |
| Salva Francisco D. | BUY | +4,064,050 | $0.12 | 03/18/2026 | 03/20/2026 |
| Salva Francisco D. | BUY | +4,064,050 | $0.12 | 03/18/2026 | 03/20/2026 |
| Schroer John R. | BUY | +3,003 | $0.30 | 12/19/2025 | 12/22/2025 |
| Staskey Norm | BUY | +15,015 | $0.30 | 12/19/2025 | 12/22/2025 |
| Ryan Barbara | BUY | +3,003 | $0.30 | 12/19/2025 | 12/22/2025 |
| Salva Francisco D. | BUY | +59,309 | $0.30 | 12/19/2025 | 12/22/2025 |
| Whitfill Travis | BUY | +23,724 | $0.30 | 12/19/2025 | 12/22/2025 |
| Staskey Norm | BUY | +47,600 | $0.21 | 03/29/2024 | 04/01/2024 |
| Salva Francisco D. | BUY | +333,300 | $0.30 | 02/13/2024 | 02/15/2024 |
| Staskey Norm | BUY | +3,300 | $0.30 | 02/13/2024 | 02/15/2024 |
| Whitfill Travis | BUY | +15,000 | $0.30 | 02/13/2024 | 02/15/2024 |
| Ryan Barbara | BUY | +10,000 | $2.07 | 09/08/2023 | 10/03/2023 |
| Schroer John R. | BUY | +10,000 | $2.07 | 09/08/2023 | 10/03/2023 |
| Whitfill Travis | BUY | +10,000 | $2.07 | 09/08/2023 | 10/03/2023 |